Cargando…

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes

The impact of the coronavirus disease 2019 (COVID-19) pandemic has been immense, and it continues to have lasting repercussions. While the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus primarily infects the respiratory system, other organ systems are affected, including the live...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldelli, Luke, Marjot, Thomas, Barnes, Eleanor, Barritt, A. Sidney, Webb, Gwilym J., Moon, Andrew M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840920/ https://www.ncbi.nlm.nih.gov/pubmed/36457261 http://dx.doi.org/10.5009/gnl220327

Ejemplares similares

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
por: Marjot, Thomas, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with autoimmune hepatitis
por: Marjot, Thomas, et al.
Publicado: (2021)

Determining risk factors for mortality in liver transplant patients with COVID-19
por: Webb, Gwilym J, et al.
Publicado: (2020)

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients
por: Webb, Gwilym J., et al.
Publicado: (2021)

COVID-19 and liver transplantation: the jury is still out – Authors' reply
por: Webb, Gwilym J, et al.
Publicado: (2021)

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination
por: Moon, Andrew M., et al.
Publicado: (2021)

COVID-19 and liver disease: mechanistic and clinical perspectives
por: Marjot, Thomas, et al.
Publicado: (2021)

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
por: Webb, Gwilym J, et al.
Publicado: (2020)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
por: Marjot, Thomas, et al.
Publicado: (2021)

Humoral and cellular immune responses to wild-type and omicron (B.1.1.529) SARS-CoV-2 variants following a fourth COVID-19 vaccination in liver transplant recipients and patients with autoimmune hepatitis
por: Dimitriadis, Stavros, et al.
Publicado: (2022)

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard
por: Moon, Andrew M., et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
por: Harrison, Andrew G., et al.
Publicado: (2020)

Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
por: Khreefa, Zaid, et al.
Publicado: (2023)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

A review on SARS-CoV-2 and stroke pathogenesis and outcome
por: Roushdy, Tamer, et al.
Publicado: (2021)

Liver transplantation from a SARS-COV-2-positive donor: A road ahead or not
por: Kumar, Aman, et al.
Publicado: (2023)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

Epidemiology, transmission and pathogenesis of SARS-CoV-2
por: Sindhuja, Tulasi, et al.
Publicado: (2022)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
por: Khalaf, Khalil, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Substances of abuse and their effect on SAR-CoV-2 pathogenesis
por: Antwi, Ivy, et al.
Publicado: (2023)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2020)

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
por: Wang, Tingyan, et al.
Publicado: (2021)

Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab
por: Jackson, Emma Marguerite, et al.
Publicado: (2022)

Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2
por: Saadi, Fareeha, et al.
Publicado: (2021)

Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
por: Amirfakhryan, Hamideh, et al.
Publicado: (2021)

Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters
por: Sia, Sin Fun, et al.
Publicado: (2020)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
por: Sun, Shi-Hui, et al.
Publicado: (2020)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2
por: Simsek, Cem, et al.
Publicado: (2021)

Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2
por: Lee, Su Jin, et al.
Publicado: (2022)

Special Issue “SARS-CoV-2: Epidemiology and Pathogenesis”: Editorial
por: Calistri, Paolo, et al.
Publicado: (2023)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7rn8lsngbp3keehfrt218p8gia